These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27388016)

  • 1. Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.
    Harada K; Baba Y; Shigaki H; Ishimoto T; Miyake K; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Kurashige J; Iwatsuki M; Miyamoto Y; Sakamoto Y; Yoshida N; Watanabe M; Baba H
    BMC Cancer; 2016 Jul; 16():400. PubMed ID: 27388016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon 9 Mutation of
    Seo AN; Kang BW; Bae HI; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Jeon SW; Kang H; Kim JG
    Anticancer Res; 2019 Apr; 39(4):2145-2154. PubMed ID: 30952761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the Prevalence of Somatic Mutations in PIK3CA Gene in Tumors and Clinical and Morphological Characteristics of Breast Cancer Patients.
    Filipenko ML; Os'kina NA; Oskorbin IA; Mishukova OV; Ovchinnikova LK; Gershtein ES; Kushlinskii NE
    Bull Exp Biol Med; 2017 Jun; 163(2):250-254. PubMed ID: 28726194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
    Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
    World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer.
    Ito C; Nishizuka SS; Ishida K; Uesugi N; Sugai T; Tamura G; Koeda K; Sasaki A
    J Surg Res; 2017 May; 212():195-204. PubMed ID: 28550907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
    Shi J; Yao D; Liu W; Wang N; Lv H; Zhang G; Ji M; Xu L; He N; Shi B; Hou P
    BMC Cancer; 2012 Feb; 12():50. PubMed ID: 22292935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review.
    Zhou L; Baba Y; Kitano Y; Miyake K; Zhang X; Yamamura K; Kosumi K; Kaida T; Arima K; Taki K; Higashi T; Imai K; Hashimoto D; Yamashita Y; Chikamoto A; Beppu T; Tan X; Baba H
    Med Oncol; 2016 Apr; 33(4):32. PubMed ID: 26927447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer.
    Iranpour M; Nourian M; Saffari S; Samizadeh E; Mirghafori M; Iravani S; Ghafouri-Fard S
    Iran Biomed J; 2019 Jan; 23(1):87-91. PubMed ID: 29704890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer.
    Dirican E; Kaya Z; Gullu G; Peker I; Ozmen T; Gulluoglu BM; Kaya H; Ozer A; Akkiprik M
    Asian Pac J Cancer Prev; 2014; 15(21):9327-33. PubMed ID: 25422220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of
    Shen X; Zhao Y; Chen X; Sun H; Liu M; Zhang W; Jiang F; Li P
    Future Oncol; 2019 Jun; 15(16):1873-1894. PubMed ID: 30920860
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations.
    Böger C; Krüger S; Behrens HM; Bock S; Haag J; Kalthoff H; Röcken C
    Ann Oncol; 2017 May; 28(5):1005-1014. PubMed ID: 28453696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Shigaki H; Baba Y; Watanabe M; Murata A; Ishimoto T; Iwatsuki M; Iwagami S; Nosho K; Baba H
    Clin Cancer Res; 2013 May; 19(9):2451-9. PubMed ID: 23532889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.
    Cheng J; Fu S; Wei C; Tania M; Khan MA; Imani S; Zhou B; Chen H; Xiao X; Wu J; Fu J
    Cancer Biomark; 2017; 19(1):85-92. PubMed ID: 28269754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.
    Harlé A; Lion M; Lozano N; Husson M; Harter V; Genin P; Merlin JL
    Oncol Rep; 2013 Mar; 29(3):1043-52. PubMed ID: 23314198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.
    Schneck H; Blassl C; Meier-Stiegen F; Neves RP; Janni W; Fehm T; Neubauer H
    Mol Oncol; 2013 Oct; 7(5):976-86. PubMed ID: 23895914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR.
    Zeng Q; Xie L; Zhou N; Liu M; Song X
    Mol Diagn Ther; 2017 Aug; 21(4):443-451. PubMed ID: 28247181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.
    Fang WL; Huang KH; Lan YT; Lin CH; Chang SC; Chen MH; Chao Y; Lin WC; Lo SS; Li AF; Wu CW; Chiou SH; Shyr YM
    Oncotarget; 2016 Feb; 7(5):6201-20. PubMed ID: 26701847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PIK3CA gene mutations in Chinese women with HR
    Wu SF; Wang XF; Liu YY; Xia C; Liang ZY; Zeng X
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1246-1250. PubMed ID: 36480834
    [No Abstract]   [Full Text] [Related]  

  • 19. Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma.
    Basu M; Chakraborty B; Ghosh S; Samadder S; Dutta S; Roy A; Pal DK; Ghosh A; Panda CK
    Mutagenesis; 2020 Dec; 35(6):499-508. PubMed ID: 33400797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene.
    Polom K; Marrelli D; Roviello G; Pascale V; Voglino C; Vindigni C; Generali D; Roviello F
    Adv Clin Exp Med; 2018 Jul; 27(7):963-969. PubMed ID: 29905413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.